Skip to main content
Premium Trial:

Request an Annual Quote

Opportunities in India

Within India's growing biotech industry, "most jobs are currently available in the private sector and for research and development, marketing, sales/business development, and customer support," The Economic Times reports. Covering a recent talk given by Novozyme's GS Krishnan, vice president of the firm's India/Bangalore presence, The Economic Times adds that "demand at the entry level in the biotechnology industry may not be encouraging [as] the industry is still at a nascent stage in India." Still, according to Krishnan, "career opportunities in fields such as bio-pharmacy, bio-service, bio-agriculture, bio-industrial and bio-informatics is burgeoning."

During the same session, Merck Serono's Lawrence Ganti, general manager/country head for India, said that "many pharmaceutical companies have established R&D centers in India and are considering tapping India's talent." He adds that "graduates with good academic results, relevant experience, and strong soft skills can look forward to a range of positions in the field."

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.